Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AQP1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
AQP1 is a gene implicated in neurodegeneration research. Key relationships include: expressed in, activates, therapeutic target. Associated with ALS, Aging, Als. Connected to 117 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | AQP1 |
| Full Name | Aquaporin 1 |
| Chromosome | 7p14.3 |
| Protein Type | Channel |
| Target Class | Ion Channel |
| Function | encodes a water channel protein that facilitates rapid water transport across cell membranes. |
| Mechanism of Action | AQP1 functions as a water channel protein facilitating transmembrane water flux, with emerging evidence suggesting its involvement in neuroinflammatory processes and potential contribution to neuronal cell volume regulation and edema formation in neurodegenerative conditions. In the context of neurodegeneration, AQP1 may modulate neuronal and glial cell responses to oxidative stress, inflammation, and cellular metabolic perturbations, making it a potential strategic target for therapeutic intervention. |
| Primary Expression | the central nervous system, particularly in the choroid plexus, where it plays a critical role in [cerebrospinal fluid ( |
| Druggability | Low (0.39) |
| Clinical Stage | Approved |
| Molecular Weight | 28 kDa |
| Pathways | Angiogenesis, Complement, Epigenetic, Glycolysis, Immune Response |
| UniProt ID | P29972 |
| NCBI Gene ID | 358 |
| Ensembl ID | ENSG00000240583 |
| OMIM | 107700 |
| GeneCards | AQP1 |
| Human Protein Atlas | AQP1 |
| Associated Diseases | aging, Als, Alzheimer |
| Known Drugs/Compounds | H2O2, Hydrogen Peroxide |
| Interactions | AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AND, APOPTOSIS, App |
| SciDEX Target | View Target Profile (6 clinical trials) |
| SciDEX Hypotheses | Osmotic Gradient Restoration via Selective AQP1 En |
| KG Connections | 294 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
AQP1["AQP1"] -->|"regulates"| Endothelial_Cell_Senescence["Endothelial Cell Senescence"]
AQP1["AQP1"] -->|"mediates"| Water_Transport["Water Transport"]
AQP1["AQP1"] -->|"interacts"| H2O2["H2O2"]
AQP1["AQP1"] -->|"modulates"| Cell_Cycle_Arrest["Cell-Cycle Arrest"]
AQP1["AQP1"] -->|"modulates"| Senescence_Associated_Secretor["Senescence-Associated Secretory Phenotype"]
AQP1["AQP1"] -->|"expressed in"| Aortic_Endothelial_Cells["Aortic Endothelial Cells"]
h_0dea0ed5["h-0dea0ed5"] -->|"targets"| AQP1["AQP1"]
HDAC4["HDAC4"] -.->|"inhibits"| AQP1["AQP1"]
MEF2A["MEF2A"] -.->|"inhibits"| AQP1["AQP1"]
AQP4["AQP4"] -->|"associated"| AQP1["AQP1"]
style AQP1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Water Transport | mediates | process | 0.95 |
| Endothelial Cell Senescence | regulates | process | 0.95 |
| Central Nervous System | expressed_in | cell_type | 0.90 |
| Angiogenesis | regulates | process | 0.90 |
| Central Nervous System Injury | involved_in | disease | 0.90 |
| Endothelial Cells | expressed_in | cell_type | 0.90 |
| Angiogenic Capacity | promotes | phenotype | 0.90 |
| Cell-Cycle Arrest | regulates | process | 0.85 |
| Senescence-Associated Secretory Phenotype | regulates | phenotype | 0.85 |
| peripheral nervous system | expressed_in | brain_region | 0.85 |
| H2O2 | transports | compound | 0.85 |
| Edema | contributes_to | phenotype | 0.85 |
| Water Transport | involved_in | process | 0.85 |
| H2O2 | interacts_with | compound | 0.85 |
| Dna Damage Response | modulates | process | 0.85 |
| Mitochondrial Dysfunction | modulates | phenotype | 0.85 |
| Dna Damage Response | regulates | process | 0.85 |
| Cerebral Edema | involved_in | disease | 0.85 |
| Hydrogen Peroxide | interacts_with | compound | 0.85 |
| CNS Injury | involved_in | disease | 0.85 |
| Glioblastoma Multiforme | involved_in | disease | 0.80 |
| AQP4 | associated_with | gene | 0.80 |
| Alzheimer'S Disease | associated_with | disease | 0.80 |
| cardiovascular disease | implicated_in | disease | 0.80 |
| Spinal Cord Injury | involved_in | phenotype | 0.80 |
| endothelial cell senescence | orchestrates | process | 0.80 |
| Parkinson'S Disease | involved_in | disease | 0.80 |
| Cell-Cycle Arrest | modulates | phenotype | 0.80 |
| Senescence-Associated Secretory Phenotype | modulates | phenotype | 0.80 |
| Multiple Sclerosis | involved_in | disease | 0.80 |
| Amyotrophic Lateral Sclerosis | involved_in | disease | 0.80 |
| Aortic Endothelial Cells | expressed_in | cell_type | 0.75 |
| mitochondrial dysfunction | causes | phenotype | 0.75 |
| Inflammation | activates | disease | 0.75 |
| metabolic dysfunction | modulates | phenotype | 0.75 |
| TGF-beta signaling | participates_in | pathway | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| Senescence | regulates | disease | 0.65 |
| Sepsis | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Cardiac | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Als | transports | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-0dea0ed5 | targets | hypothesis | 0.90 |
| CX43 | expressed_in | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| BACE1 | activates | gene | 0.60 |
| AQP4 | inhibits | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| AQP3 | inhibits | gene | 0.60 |
| AQP5 | associated_with | gene | 0.60 |
| BCL-2 | expressed_in | gene | 0.60 |
| CANX | regulates | gene | 0.60 |
| APP/PS1 | associated_with | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| AQP3 | expressed_in | gene | 0.60 |
| CAMKII | transports | gene | 0.60 |
| HDAC4 | inhibits | gene | 0.60 |
| MEF2A | inhibits | gene | 0.60 |
| AQP4 | associated_with | gene | 0.60 |
| CFTR | regulates | gene | 0.60 |
| GAT1 | regulates | gene | 0.60 |
| AQP4 | expressed_in | gene | 0.60 |
| CFTR | transports | gene | 0.60 |
| GAT1 | transports | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| CASPASE3 | expressed_in | gene | 0.60 |
| BAX | expressed_in | gene | 0.60 |
| angiogenesis | regulates | process | 0.60 |
| angiogenesis | activates | process | 0.60 |
| DNA | regulates | gene | 0.60 |
| AQP5 | expressed_in | gene | 0.60 |
| AQP9 | expressed_in | gene | 0.60 |
| AQP5 | transports | gene | 0.60 |
| ABCC8 | associated_with | gene | 0.60 |
| AMPK | transports | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| ASTROCYTE | expressed_in | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| PARKINSON | expressed_in | gene | 0.60 |
| AGING | inhibits | gene | 0.60 |
| GLIOBLASTOMA | expressed_in | gene | 0.60 |
| MIRNAS | regulates | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| APP | activates | gene | 0.55 |
| HCRTR2 | co_discussed | gene | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Osmotic Gradient Restoration via Selective AQP1 Enhancement | 0.680 | neurodegeneration | Perivascular spaces and glymphatic clear |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.860
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co | clinical | Alzheimer's Disease | 0.900 | 0.50 | aortic endothelial cells | proposed | $6,550,000 |
| CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| AQP1 differentially orchestrates endothelial cell senescence. [PMID:39180980] | Shabanian K, Shabanian T, Karsai G, Pont | Redox Biol | 2024 | 1 |
| Non-Aquaporin Water Channels. [PMID:36717505] | Huang B, Wang H, Yang B | Adv Exp Med Biol | 2023 | 1 |
| Aquaporins in Nervous System. [PMID:28258567] | Xu M, Xiao M, Li S, Yang B | Adv Exp Med Biol | 2017 | 1 |
| Aquaporins in the Spinal Cord. [PMID:27941618] | Oklinski MK, Skowronski MT, Skowronska A | Int J Mol Sci | 2016 | 1 |
| Aquaporin gating. [PMID:16837191] | Hedfalk K, Törnroth-Horsefield S, Nyblom | Curr Opin Struct Biol | 2006 | 1 |
| Panax notoginseng saponins protect the blood-brain barrier against oxidative str [PMID:41763432] | Fan L, Qu S, Miao C, Wu D, Rao Y et al. | Int J Biol Macromol | 2026 | 0 |
| Stomatin encapsulates aquaporin-1 and urea transporter-B in the erythrocyte memb [PMID:41921000] | Vallese F, Li H, Barazzuol L, Calì T, Cl | Sci Adv | 2026 | 0 |
| Aquaporin membrane channels in the hepatobiliary tract: a model of complexity an [PMID:41926019] | Portincasa P, Khalil M, Calamita G | Intern Emerg Med | 2026 | 0 |
| Glycosomal Aquaglyceroporin 1 dual role in iron homeostasis and antimony suscept [PMID:41926379] | Boy RL, Zampieri RA, Aoki JI, Coelho AC, | PLoS Negl Trop Dis | 2026 | 0 |
| Aquaporin-1 Facilitates Macrophage M1 Polarization by Enhancing Glycolysis Throu [PMID:39365391] | ["Diao R", "Lv W", "Wang Y", "Shen Q", " | Inflammation | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. [PMID:34670044] | Morelle J, Marechal C, Yu Z, Debaix H, C | The New England journal of med | 2021 | 0 |
| Discovery of novel diarylamides as orally active diuretics targeting urea transp [PMID:33532188] | ["Zhang S", "Zhao Y", "Wang S", "Li M", | Acta pharmaceutica Sinica. B | 2021 | 0 |
| Physiological and pathological impact of AQP1 knockout in mice. [PMID:31023968] | Hua Y, Ying X, Qian Y, Liu H, Lan Y, Xie | Bioscience reports | 2019 | 0 |
| The potential role of aquaporin 1 on aristolochic acid I induced epithelial mese [PMID:29215709] | ["Li J", "Zhang M", "Mao Y", "Li Y", "Zh | Journal of cellular physiology | 2018 | 0 |
| Cardiotrophin-1 predicts death or heart failure following acute myocardial infar [PMID:17045183] | ["Khan S", "Kelly D", "Quinn P", "Davies | Journal of cardiac failure | 2006 | 0 |
| Regulation of mitosis in response to damaged or incompletely replicated DNA requ [PMID:16079276] | ["Purdy A", "Uyetake L", "Cordeiro M", " | Journal of cell science | 2005 | 0 |
| Physiological roles of aquaporins in the choroid plexus. [PMID:15949534] | Boassa D, Yool AJ | Current topics in developmenta | 2005 | 0 |
| Structural basis of ion pumping by Ca2+-ATPase of the sarcoplasmic reticulum. [PMID:15189143] | ["Toyoshima C", "Inesi G"] | Annual review of biochemistry | 2004 | 0 |
| Su e of the yeast F1Fo-ATP synthase forms homodimers. [PMID:12377768] | ["Brunner S", "Everard-Gigot V", "Stuart | The Journal of biological chem | 2002 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning AQP1 in their description or question text
No additional research found